Determinants of blood telomere length in antiretroviral treatment-naïve HIV-positive participants enrolled in the NEAT 001/ANRS 143 clinical trial

Determinants of blood telomere length in antiretroviral treatment-naïve HIV-positive participants enrolled in the NEAT 001/ANRS 143 clinical trial. Alejos, B.; Stella-Ascariz, N.; Montejano, R.; Rodriguez-Centeno, J.; Schwimmer, C.; Bernardino, J. I.; Rodes, B.; Esser, S.; Goujard, C.; Sarmento-Castro, R.; De Miguel, R.; Esteban-Cantos, A.; Wallet, C.; Raffi, F.; Arribas, J. R.; NEAT 001/ANRS 143 Study Group. HIV medicine. 2019; 20: p.691-698. doi:10.1111/hiv.12791
Article